Australian Capital Territory
Drugs of Dependence Regulations 1993     No 14
made under the
Drugs of Dependence Act 1989
Republication No 2
Republication date: 12 September 2001
Last amendment made by Act 2001 No 44
Amendments incorporated to 12 September 2001

Unauthorised version prepared by ACT Parliamentary Counsel's Office

About this republication
The republished law
This is a republication of the Drugs of Dependence Regulations 1993, made under the Drugs of Dependence Act 1989 as in force on 12 September 2001.  It includes any amendment, repeal or expiry affecting the republished law to 12 September 2001 and any amendments made under the Legislation Act 2001, part 11.3 (Editorial changes).  
The legislation history and amendment history of the republished law are set out in endnotes 3 and 4. 
Kinds of republications
The Parliamentary Counsel’s Office prepares 2 kinds of republications of ACT laws (see the ACT legislation register at www.legislation.act.gov.au):
•	authorised republications to which the Legislation Act 2001 applies
•	unauthorised republications.
The status of this republication appears on the bottom of each page.
Editorial changes
The Legislation Act 2001, part 11.3 authorises the Parliamentary Counsel to make editorial amendments and other changes of a formal nature when preparing a law for republication.  Editorial changes do not change the effect of the law, but have effect as if they had been made by an Act commencing on the republication date (see Legislation Act 2001, s 115 and s 117).  The changes are made if the Parliamentary Counsel considers they are desirable to bring the law into line, or more closely into line, with current legislative drafting practice.  
When preparing the authorised version of this republication amendments were made under part 11.3 (see endnote 1).
Uncommenced provisions and amendments
If a provision of the republished law has not commenced or is affected by an uncommenced amendment, the symbol  U  appears immediately before the provision heading.  The text of the uncommenced provision or amendment appears only in the last endnote.
Modifications
If a provision of the republished law is affected by a current modification, the symbol  M  appears immediately before the provision heading.  The text of the modifying provision appears in the endnotes.  For the legal status of modifications, see Legislation Act 2001, section 95.
Penalties
The value of a penalty unit for an offence against this republished law at the republication date—
	(a)	if the person charged is an individual—$100; or
	(b)	if the person charged is a corporation—$500.

Amendments incorporated to
12 September 2001

Australian Capital Territory
Drugs of Dependence Regulations 1993
made under the
Drugs of Dependence Act 1989
Contents
	Page
	1	Citation	2
	4	Drugs of dependence	2
	5	Commercial quantities	2
	6	Traffickable quantities	2
Schedule 1	Drugs of dependence–general	3
Schedule 2	Prohibited substances	7
Schedule 3	Drugs of dependence–manufacturing	15
Endnotes
	1	About the endnotes	16
	2	Abbreviation key	16
	3	Legislation history	17
	4	Amendment history	17
	5	Earlier republications	18

Amendments incorporated to
12 September 2001

Australian Capital Territory
Drugs of Dependence Regulations 1993     

made under the
Drugs of Dependence Act 1989

    

  

1	Citation
These regulations may be cited as the Drugs of Dependence Regulations 1993.
4	Drugs of dependence
For the Act, section 4, definition of drug of dependence, the substances specified in schedule 3 are prescribed.
5	Commercial quantities
For the Act, section 160 (1), definition of commercial quantity—
	(a)	the prescribed quantity of a drug of dependence specified in schedule 1, column 2 is the quantity specified in the appropriate column or columns of schedule 1 opposite the reference to that drug; and
	(b)	the prescribed quantity of a prohibited substance specified in schedule 2, column 2 is the quantity specified in the appropriate column or columns of schedule 2 opposite the reference to that substance.
6	Traffickable quantities
For the Act, section 160 (1), definition of traffickable quantity—
	(a)	the prescribed quantity of a drug of dependence specified in schedule 1, column 2 is the quantity specified in the appropriate column or columns of schedule 1 opposite the reference to that drug; and
	(b)	the prescribed quantity of a prohibited substance specified in schedule 2, column 2 is the quantity specified in the appropriate column or columns of schedule 2 opposite the reference to that substance.

Schedule 1	Drugs of dependence–general
(see reg 5 and reg 6)

column 1

item	column 2

drug	column 3
traffickable quantity (grams)	column 4
commercial quantity (kilograms)
	
1	Acetyldihydrocodeine	2.00	2.00	
2	Acetylmethadol	2.00	2.00	
3	Acetylmorphines	2.00	2.00	
4	Alfentanil	0.005	0.005	
5	Alphacetylmethadol	10.00	10.00	
6	Alphaprodine	25.00	25.00	
7	Amphetamine	2.00	2.00	
8	Amylobarbitone, except when packed and labelled for injection	
20.00	
20.00	
9	Anileridine	25.00	25.00	
10	Benzylmorphine	5.00	5.00	
11	Bezitramide	5.00	5.00	
12	Buprenorphine	0.05	0.05	
13	Butobarbitone	20.00	20.00	
14	Butorphanol	2.00	2.00	
15	Carfentanyl	0.005	0.005	
16	Cocaine	2.00	2.00	
17	Codeine, except when compounded with 1 or more other medicaments—			
	(a)	in divided preparations containing 30 mg or less of codeine per dosage unit; or			
	(b)	in undivided preparations containing 1% or less of codeine	
10.00	
10.00	
18	Codeine-N-oxide	10.00	10.00	
19	Concentrate of Poppy Straw (the material arising when poppy straw has entered into a process for concentration of its alkaloids)	

250.00	

250.00	
20	4-Cyano-1-methyl-4-phenylpiperidine (Pethidine intermediate A)	
10.00	
10.00	
21	Cyclobarbitone	20.00	20.00	
22	Dexamphetamine	2.00	2.00	
23	Dextromoramide	2.00	2.00	
24	Dextropropoxyphene, except when—			
	(a)	in divided preparations containing 135 mg or less of dextropropoxyphene per dosage unit; or			
	(b)	in liquid preparations containing 2.5% or less of dextropropoxyphene	
27.00	
27.00	
25	Difenoxin, except in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin	

2.00	

2.00	
26	Dihydrocodeine, except when compounded with 1 or more other medicaments—			
	(a)	in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or			
	(b)	in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine	

10.00	

10.00	
27	Dihydromorphine	10.00	10.00	
28	Diphenoxylate, except in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate	

2.00	

2.00	
29	Dipipanone	10.00	10.00	
30	Dronabinol	6.00	6.00	
31	Drotebanol	2.00	2.00	
32	Ethylamphetamine	2.00	2.00	
33	Ethylmorphine, except when compounded with 1 or more other medicaments—			
	(a)	in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or			
	(b)	in undivided preparations with a concentration of not more than 2.5% of ethylmorphine 	

2.00	

2.00	
34	Fentanyl	0.005	0.005	
35	Flunitrazepam	0.40	0.40	
36	Hydrocodone	2.00	2.00	
37	Hydromorphinol	2.00	2.00	
38	Hydromorphone	2.00	2.00	
39	Levamphetamine	2.00	2.00	
40	Levomethamphetamine	2.00	2.00	
41	Levomoramide	2.00	2.00	
42	Levorphanol	1.00	1.00	
43	Methadone	2.00	2.00	
44	Methamphetamine	2.00	2.00	
45	Methyldihydromorphine	2.00	2.00	
46	Methylphenidate	2.00	2.00	
47	1-Methyl-4-phenylpiperidine-4-carboxylic Acid (Pethidine intermediate C)	
10.00	
10.00	
48	Morphine	2.00	1.50	
49	Morphine Methobromide	2.00	1.00	
50	Morphine-N-oxide	2.00	2.00	
51	Nabilone	0.40	0.40	
52	Norcodeine	2.00	2.00	
53	Normethadone	5.00	5.00	
54	Opium in any form, except the alkaloids noscapine and  papaverine	
20.00	
20.00	
55	Oxycodone	5.00	5.00	
56	Oxymorphone	2.00	2.00	
57	Pentazocine	20.00	20.00	
58	Pentobarbitone, except when packed and labelled for injection	
20.00	
20.00	
59	Pethidine	10.00	10.00	
60	Phendimetrazine	5.00	5.00	
61	Phenmetrazine	5.00	5.00	
62	Phenoperidine	1.00	1.00	
63	4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester (Pethidine intermediate B)	
10.00	
10.00	
64	Pholcodine, except when compounded with 1 or more other medicaments—			
	(a)	in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or			
	(b)	in undivided preparations with a concentration of not more than 2.5% of pholcodine 	

5.00	

5.00	
65	Piritramide	1.00	1.00	
66	Propiram	10.00	10.00	
67	Quinalbarbitone	20.00	20.00	
68	Racemoramide	2.00	2.00	
69	Remifentanil	1.00	1.00	
70	Secbutobarbitone	20.00	20.00	
71	Sufentanil	0.005	0.005	
72	Thebacon	2.00	2.00	
73	Thebaine	2.00	2.00	
74	Tilidine	20.00	20.00	
75	A substance which is, in relation to a drug of dependence specified elsewhere in this schedule—			
	(a)	an active principle of that drug;			
	(b)	a preparation or admixture of that drug; or			
	(c)	a salt of that drug or active principle; 			
	except where the substance is separately specified in this schedule	
The minimum traffickable quantity and the minimum commercial quantity, respectively, of—	
		(a)	the drug of dependence in relation to which the substance is specified in this item; or	
		(b)	if there is more than 1 such drug—the drug referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.	

Schedule 2	Prohibited substances
(see reg 5 and reg 6)

column 1

item	column 2

substances	column 3
traffickable quantity (grams	column 4
commercial quantity (kilograms)	
1	Acetorphine	2.00	2.00	
2	Acetyl- a-methylfentanyl	0.005	0.005	
3	Alkoxyamphetamines and bromo-substituted alkoxyamphetamines, except where separately specified in this schedule	

0.50	

0.50	
4	Alkoxyphenethylamines and alkyl-substituted alkoxyphenethylamines, except where separately specified in this schedule	

0.50	

0.50	
5	Allylprodine	2.00	2.00	
6	Alphameprodine	0.20	0.20	
7	Alphamethadol 	0.20	0.20	
8	2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM)	
0.50	
0.50	
9	Benzethidine	10.00	10.00	
10	Betacetylmethadol	5.00	5.00	
11	Betameprodine	5.00	5.00	
12	Betamethadol	5.00	5.00	
13	Betaprodine	5.00	5.00	
14	4-Bromo-3,5-dimethoxyamphetamine	0.50	0.50	
15	4-Bromo-2,5-dimethoxyphenethylamine (BDMPEA)	
0.50	
0.50	
16	3-Bromo-4-methoxyamphetamine	0.50	0.50	
17	4-Bromo-3-methoxyamphetamine	0.50	0.50	
18	Bufotenine	2.00	2.00	
19	Cannabis	100.00	100.00	
20	Cannabis Oil	2.00	2.00	
21	Cannabis Resin	20.00	50.00	
22	Cathinone	2.00	2.00	
23	Clonitazene	5.00	5.00	
24	Coca Leaf	250.00	80.00	
25	Codoxime	10.00	10.00	
26	4-Cyano-2-dimethylamino-4,4-diphenylbutane (Methadone intermediate)	
2.00	
2.00	
27	Desomorphine	2.00	2.00	
28	Diampromide	5.00	5.00	
29	Diethylthiambutene	5.00	5.00	
30	N,N-Diethyltryptamine (DET)	2.00	2.00	
31	Dimenoxadol	10.00	10.00	
32	Dimepheptanol	10.00	10.00	
33	2,4-Dimethoxyamphetamine	0.50	0.50	
34	3,4-Dimethoxyamphetamine	0.50	0.50	
35	2,5-Dimethoxy-4-bromoamphetamine (DOB)	
0.50	
0.50	
36	3,4-Dimethoxy-5-ethoxyamphetamine	0.50	0.50	
37	2,5-Dimethoxy-4-ethoxyamphetamine	0.50	0.50	
38	4,5-Dimethoxy-2-ethoxyamphetamine	0.50	0.50	
39	2,5-Dimethoxy-4-ethyl- a-methylphenylethylamine (DOET)	
0.50	
0.50	
40	2,3-Dimethoxy-4,5-methylenedioxyamphetamine	
0.50	
0.50	
41	2,5-Dimethoxy-3,4-methylenedioxyamphetamine	
0.50	
0.50	
42	2,5-Dimethoxy - a-methylphenyleth ylamine (DMA)	
0.50	
0.50	
43	3,4-Dimethoxyphenylethylamine	0.50	0.50	
44	3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine, Psilotsin)	
2.00	
2.00	
45	3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (DMHP)	

2.00	

2.00	
46	Dimethylthiambutene	20.00	20.00	
47	N,N,-Dimethyltryptamine (DMT)	2.00	2.00	
48	Dioxaphetyl Butyrate	2.00	2.00	
49	Ecgonine	10.00	10.00	
50	4,5-Ethylenedioxy-3-methoxyamphetamine	0.50	0.50	
51	Ethylmethylthiambutene	10.00	10.00	
52	Eticyclidine (PCE)	2. 00	2.00	
53	Etonitazene	5.00	5.00	
54	Etorphine	5.00	2.00	
55	Etoxeridine	5.00	5.00	
56	Fenetylline	2.00	2.00	
57	Furethidine	1.00	1.00	
58	Harmaline	2.00	2.00	
59	Harmine	2.00	2.00	
60	Heroin	2.00	1.50	
61	3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran (Parahexyl)	

2.00	

2.00	
62	4-Hydroxy-butanoic acid	0.50	0.50	
64	-Hydroxyfentanyl	0.005	0.005	
65	-Hydroxy-3-methylfentanyl	0.005	0.005	
66	Hydroxypethidine	5.00	5.00	
67	Isomethadone	2.00	2.00	
68	Ketobemidone	2.00	2.00	
69	Levomethorphn	2.00	2.00	
70	Levophenacylmorphan	2.00	2.00	
71	Lysergic Acid	0.002	0.002	
72	Lysergide (LSD, LSD-25)	0.002	0.002	
73	Mecloqualone	60.00	60.00	
74	Mescaline-see 3,4,5-Trimethoxyphenethylamine 			
75	Metazocine	7.00	7.00	
76	Methaqualone	50.00	50.00	
77	2-Methoxy-3, 4-methylenedioxyamphetamine	
50.00	
50.00	
78	2-Methoxy-4, 5-methylenedioxyamphetamine	
0.50	
0.50	
79	4-Methoxy-2, 3-methylenedioxyamphetamine	
0.50	
0.50	
80	5-Methoxy-3, 4-methylenedioxy- a-methylphenylethylamine (MMDA)	
0.50	
0.50	
81	2-Methoxy-3, 4-methylenedioxyphenylethylamine	
0.50	
0.50	
82	3-Methoxy-4, 5-methylenedioxyphenylethylamine	
0.50	
0.50	
83	4-Methoxy- a-methylphenylethylamine (PMA)	
0.50	
0.50	
84	4-Methoxyphenylethylamine	0.50	0.50	
85	4-Methylaminorex	2.00	2.00	
86	Methyldesorphine	2.00	2.00	
87	3, 4-Methylenedioxyamphetamine (MDA)	0.50	0.50	
88	3, 4-Methylenedioxy-N, a-dimethylphenylethylamine (MDMA)	
0.50	
0.50	
89	3, 4-Methylenedioxy-N-ethylamphetamine (MDE)	
0.50	
0.50	
90	3-Methylfentanyl	0.005	0.005	
91	a -Methylfentanyl	0.005	0.005	
92	2-Methyl-3-morpholino-1,1-diphenylpropane Carboxylic Acid (Moramide intermediate)	
8.00	
8.00	
93	1-Methyl-4-phenyl-4-piperidinol propionate (MPPP)	
2.00	
2.00	
94	3-Methylthiofentanyl	0.005	0.005	
95	a-Methylthiofentanyl	0.005	0.005	
96	Metopon	2.00	2.00	
97	Morpheridine	2.00	2.00	
98	Muscimol	2.00	2.00	
99	Myrophine	20.00	20.00	
100	Nicocodine	2.00	2.00	
101	Nicodicodine	2.00	2.00	
102	Nicomorphine	2.00	2.00	
103	Noracymethadol	2.00	2.00	
104	Norlevorphanol	2.00	2.00	
105	Normorphine	20.00	20.00	
106	Norpipanone	10.00	10.00	
107	Para-fluorofentanyl	0.005	0.005	
108	Phenadoxone	10.00	10.00	
109	Phenampromide	10.00	10.00	
110	Phenazocine	1.00	1.00	
111	Phencyclidine (PCP)	2.00	2.00	
112	Phenomorphan	5.00	5.00	
113	1-Phenylethyl-4-phenyl-4-piperidinol acetate (PEPAP)	
2.00	
2.00	
114	Piminodine	10.00	10.00	
115	Proheptazine	1.00	1.00	
116	Properidine	25.00	25.00	
117	Psilocine—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole 			
118	Psilocybine	2.00	2.00	
119	Psilotsin—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole 			
120	Racemethorphan	2.00	2.00	
121	Racemorphan	2.00	2.00	
122	Rolicyclidine (PHP, PCPY)	2.00	2.00	
123	Tenocyclidine (TCP)	2.00	2.00	
124	Tetrahydrocannabinols (THC) and their alkyl homologues, except where separately specified in schedule 1 or this schedule	

2.00	

5.00	
125	2, 3, 4, 5-Tetramethoxyamphetamine	0.50	0.50	
126	Thiofentanyl	0.005	0.005	
127	Trimeperidine	10.00	10.00	
128	2, 3, 4-Trimethoxyamphetamine	0.50	0.50	
129	2, 3, 5-Trimethoxyamphetamine	0.50	0.50	
130	2, 3, 6-Trimethoxyamphetamine	0.50	0.50	
131	2, 4, 5-Trimethoxyamphetamine	0.50	0.50	
132	2, 4, 6-Trimethoxyamphetamine	0.50	0.50	
133	3, 4, 5-Trimethoxy- a-methylphenylethylamine (TMA)	
0.50	
0.50	
134	3, 4, 5-Trimethoxyphenethylamine (mescaline) and other substances structurally derived from methoxy-phenylethylamine, except—			
	(a)	methoxyphenamine; or			
	(b)	where separately specified in this schedule	
7.50	
7.50	
135	1-(3, 4, 5-Trimethoxyphenyl)-2-aminobutane	0.50	0.50	
136	2, 4, 5-Trimethoxyphenylethylamine	0.50	0.50	
137	A substance which is, in relation to a prohibited substance specified elsewhere in this schedule—			
	(a)	an active principle of that prohibited substance;			
	(b)	a preparation or admixture of that prohibited substance; or			
	(c)	a salt of that prohibited substance or active principle;			
	except where the firstmentioned substance is separately specified in this schedule	
The minimum traffickable quantity and the minimum commercial quantity, respectively, of—	
		(a)	the prohibited substance in relation to which the substance is specified in this item; or	
		(b)	if there is more than 1 such prohibited substance—the prohibited substance referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.	
138	A substance (drug analogue) which is, in relation to another substance (being a drug of dependence or a substance specified elsewhere in this schedule, or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a drug or substance)—
		
	(a)	a stereoisomer; or		
	(b)	a structural isomer having the same constituent groups; or		
	(c)	an alkaloid; or		
	(d)	a structural modification notionally obtained in 1 or more of the following ways:		
	(i)	by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;		
	(ii)	by the addition of hydrogen atoms to 1 or more unsaturated bonds;		
	(iii)	by the addition of 1 or more of the following groups, namely alkoxy, cyclic diether, acyl, acyloxy, mono-amino and dialkylamino groups with up to 6 carbon atoms in any alkyl residue; alkyl, alkenyl and alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon; and halogen, hydroxy, nitro and amino groups;		
	(iv)	by the replacement of 1 or more of the groups specified in subparagraph (iii) with another such group or groups;		
	(v)	by the conversion of a carboxyl or an ester group into an amide group; or		
	(e)	otherwise an homologue, analogue, chemical derivative or substance substantially similar in chemical structure;		
	however manufactured or actually obtained, except where the drug analogue—		
	(f)	is a drug of dependence; or		
	(g)	is separately specified in this schedule; or		
	(h)	is specified in a schedule to the Poisons and Drugs Act 1978; or		
	(i)	is specified in the Public Health (Prohibited Drugs) Act 1957, schedule 	

The minimum traffickable quantity and the minimum commercial quantity, respectively, of—	
		(a)	the drug of dependence or prohibited substance in relation to which the substance is a drug analogue; or	
		(b)	if there is more than 1 such drug or prohibited substance—the drug or prohibited substance referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.	

Schedule 3	Drugs of dependence–manufacturing
(see reg 4)
Table 1	
column 1
item	column 2
substance	
1	Acetylmorphines	
2	Amphetamine	
3	Amylobarbitone	
4	Buprenorphine	
5	Butobarbitone	
6	Butorphanol	
7	Carfentanyl	
8	Cyclobarbitone	
9	Dexamphetamine	
10	Dronabinol	
11	Ethylamphetamine	
12	Flunitrazepam	
13	Levamphetamine	
14	Levomethamphetamine	
15	Methamphetamine	
16	Methylphenidate	
17	Nabilone	
18	Pentazocine	
19	Pentobarbitone	
20	Phendimetrazine	
21	Phenmetrazine	
22	Quinalbarbitone	
23	Remifentanil	
24	Secbutobarbitone	
25	A substance which is, in relation to a drug of dependence specified elsewhere in this schedule—	
	(a)	an active principle of that drug; or	
	(b)	a preparation or admixture of that drug; or	
	(c)	a salt of that drug or active principle.	

Endnotes
1	About the endnotes
Amending and modifying laws are annotated in the legislation history and the amendment history.  Current modifications are not included in the republished law but are set out in the endnotes.
Not all editorial amendments made under the Legislation Act 2001, part 11.3 are annotated in the amendment history.  Full details of any amendments can be obtained from the Parliamentary Counsel’s Office.
Uncommenced amending laws are listed in the legislation history and the amendment history.  These details are underlined.  Uncommenced provisions and amendments are not included in the republished law but are set out in the last endnotes.
If all the provisions of the law have been renumbered, a table of renumbered provisions gives details of previous and current numbering.  
The endnotes also include a table of earlier republications.
If the republished law includes penalties, current information about penalty unit values appears on the republication inside front cover.
2	Abbreviation key

am = amended	ord = ordinance	
amdt = amendment	orig = original	
ch = chapter	p = page	
cl = clause	par = paragraph	
def = definition	pres = present	
dict = dictionary	prev = previous	
disallowed = disallowed by the Legislative 	(prev...) = previously	
Assembly	prov = provision	
div = division	pt = part	
exp = expires/expired	r = rule/subrule	
Gaz = Gazette	reg = regulation/subregulation	
hdg = heading	renum = renumbered	
ins = inserted/added	reloc = relocated	
LA = Legislation Act 2001	R[X] = Republication No	
LR = legislation register	s = section/subsection	
LRA = Legislation (Republication) Act 1996	sch = schedule	
mod = modified / modification	sdiv = subdivision	
No = number	sub = substituted	
o = order	SL  = Subordinate Law	
om = omitted/repealed	underlining = whole or part not commenced	

3	Legislation history
Drugs of Dependence Regulations SL 1993 No 14
notified 31 March 1993
regs 1-3 commenced 31 March 1993
remainder commenced 31 March 1993 (reg 2 (2) and Gaz 1993 No S53)
Drugs of Dependence Regulations (Amendment) SL 1995 No 29
notified 2 August 1995
commenced 2 August 1995
Drugs of Dependence Regulations (Amendment) SL 1996 No 26
notified 1 November 1996
commenced 1 November 1996
Drugs of Dependence Regulations (Amendment) SL 1998 No 20
notified 17 June 1998
reg 3 (part) commenced 19 June 1998 (reg 1 (2))
remainder 17 June 1998 (reg 1 (1))
Legislation (Consequential Amendments) Act 2001 No 44 pt 114
notified 26 July 2001 (Gaz 2001 No 30)
s 1, s 2 commenced 26 July 2001 (IA s 10B)
pt 114 commenced 12 September 2001 (s 2 and Gaz 2001 No S65)
4	Amendment history
Citation
reg 1	am R2 LA
Commencement
reg 2	om 2001 No 44 amdt 1.1224
Interpretation
reg 3	om 2001 No 44 amdt 1.1224
Drugs of dependence–general
sch 1	am 1995 No 29
	sub 1998 No 20
Prohibited substances
sch 2	am 1995 No 29; 1996 No 26
	sub 1998 No 20
Drugs of dependence–manufacturing
sch 3	sub 1998 No 20
5	Earlier republications
Some earlier republications were not numbered. The number in column 1 refers to the publication order.

Republication No	Amendments to	Republication date	
1	Act 1998 No 20	31 January 1998	

Unauthorised version prepared by ACT Parliamentary Counsel's Office

©  Australian Capital Territory 2001